日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Penaeus monodon Crustacean hyperglycemic hormones 5 (CHH5) CSB-YP527288ETF
CSB-EP527288ETF
CSB-BP527288ETF
CSB-MP527288ETF
CSB-EP527288ETF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Styela clava Clavaspirin CSB-YP527289FOV
CSB-EP527289FOV
CSB-BP527289FOV
CSB-MP527289FOV
CSB-EP527289FOV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaedon cochleariae Polygalacturonase, partial CSB-YP527290EUE
CSB-EP527290EUE
CSB-BP527290EUE
CSB-MP527290EUE
CSB-EP527290EUE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaedon cochleariae Endo-1,4-beta-xylanase CSB-YP527291EUE
CSB-EP527291EUE
CSB-BP527291EUE
CSB-MP527291EUE
CSB-EP527291EUE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Giardia intestinalis Carbamate kinase (CBK) CSB-YP527292GFW
CSB-EP527292GFW
CSB-BP527292GFW
CSB-MP527292GFW
CSB-EP527292GFW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Mitochondrial substrate carrier family protein ancA (ancA), partial CSB-YP527293DKK1
CSB-EP527293DKK1
CSB-BP527293DKK1
CSB-MP527293DKK1
CSB-EP527293DKK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chlorocebus aethiops AH receptor-interacting protein (AIP) CSB-YP527294DSU
CSB-EP527294DSU
CSB-BP527294DSU
CSB-MP527294DSU
CSB-EP527294DSU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saguinus oedipus Beta-microseminoprotein A1 (MSPA) CSB-YP527295SWB
CSB-EP527295SWB
CSB-BP527295SWB
CSB-MP527295SWB
CSB-EP527295SWB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Camelus dromedarius Alpha-S2-casein (CSN1S2) CSB-YP527296CYV
CSB-EP527296CYV
CSB-BP527296CYV
CSB-MP527296CYV
CSB-EP527296CYV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spirogyra maxima 50S ribosomal protein L2, chloroplastic (rpl2) CSB-YP527297FKM
CSB-EP527297FKM
CSB-BP527297FKM
CSB-MP527297FKM
CSB-EP527297FKM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Spirogyra maxima 30S ribosomal protein S11, chloroplastic (rps11) CSB-YP527298FKM
CSB-EP527298FKM
CSB-BP527298FKM
CSB-MP527298FKM
CSB-EP527298FKM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Barclaya longifolia Maturase K (matK), partial CSB-YP527299BSC
CSB-EP527299BSC
CSB-BP527299BSC
CSB-MP527299BSC
CSB-EP527299BSC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Maturase K (matK), partial CSB-YP527300EPQ
CSB-EP527300EPQ
CSB-BP527300EPQ
CSB-MP527300EPQ
CSB-EP527300EPQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Tecoma stans Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP527301TLP
CSB-EP527301TLP
CSB-BP527301TLP
CSB-MP527301TLP
CSB-EP527301TLP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Palmaria palmata Photosystem Q (B) protein, partial CSB-YP527302EQT1
CSB-EP527302EQT1
CSB-BP527302EQT1
CSB-MP527302EQT1
CSB-EP527302EQT1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Detonula confervacea Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP527303DJV
CSB-EP527303DJV
CSB-BP527303DJV
CSB-MP527303DJV
CSB-EP527303DJV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thalassiosira nordenskioeldii Ribulose bisphosphate carboxylase small chain (rbcS) CSB-YP527304TLY
CSB-EP527304TLY
CSB-BP527304TLY
CSB-MP527304TLY
CSB-EP527304TLY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Beaumontia grandiflora Ribulose bisphosphate carboxylase large chain (rbcL) CSB-YP527305BSN
CSB-EP527305BSN
CSB-BP527305BSN
CSB-MP527305BSN
CSB-EP527305BSN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized membrane protein C25A8.02 (SPAC25A8.02) CSB-YP527306SXV
CSB-EP527306SXV
CSB-BP527306SXV
CSB-MP527306SXV
CSB-EP527306SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Chromatin modification-related protein png1 (png1) CSB-YP527307SXV
CSB-EP527307SXV
CSB-BP527307SXV
CSB-MP527307SXV
CSB-EP527307SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×